In this study, we evaluate two Listeria monocytogenes strains that exp
ress influenza nucleoprotein (NP) sequences for their ability to prefe
ct against challenge with influenza virus. The construction of one str
ain, which expresses only the K-d restricted NP epitope (NP 147-155),
is described in this study; the other strain, which expresses the full
NP sequence in the form of a fusion protein, has been described previ
ously. The ability of the two strains to present the K-d restricted NP
epitope in vitro and induce NP-specific CTL in vivo is also described
. Mice immunized by the intravenous route with either strain cleared a
subsequent (3 weeks post-immunization) influenza virus infection more
rapidly as indicated by reduced virus titers in the lungs 5 days afte
r challenge. Efficacy of both recombinant L. monocytogenes strains as
vaccines in this system was equivalent and equal to that of recombinan
t vaccinia expressing NP. (C) 1997 Published by Elsevier Science Ltd.